The following security will be re-admitted to trading on the AQSE Growth Market with effect from 08:00 on 13/04/2021 following a reverse takeover.
Name of issuer: Apollon Formularies PLC
Ordinary Shares
ISIN: IM00BJOLRD77
Symbol: APOL
The Regulation Department
Aquis Stock Exchange
77 Cornhill London
EC3V 3QQ
Tel: 0203 597 6361
Email: aqseregulation@aquis.eu
Website: www.aquis.eu/aquis-stock-exchange
Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.